| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/03/2004 | DE10361201A1 New biologically active oligopeptides with modified termini, useful as insecticides, acaricides, antibacterials and antitumor agents, especially neoefrapeptins from Geotrichum candidum |
| 06/03/2004 | DE10252284A1 New cyclic hexapeptides containing a diaminocarboxylic acid residue, useful for, e.g. treating inflammatory or tumor diseases or as diagnostic agents, insecticides or acaricides |
| 06/02/2004 | EP1424080A1 Gnrh agonist combination drugs |
| 06/02/2004 | EP1423414A1 Novel depsipeptides and process for preparing same |
| 06/02/2004 | EP1423413A1 Peptidic compounds selectively binding to p-selectin |
| 06/02/2004 | EP1423412A2 Homing peptides |
| 06/02/2004 | EP1423140A2 Compositions and methods for modulation of immune responses |
| 06/02/2004 | EP1423137A2 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
| 06/02/2004 | EP1423135A2 Methods for inhibiting angiogenesis |
| 06/02/2004 | EP1242109A4 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 06/02/2004 | EP0981541B1 Psca: prostate stem cell antigen |
| 06/02/2004 | EP0948344A4 Synthetic antibiotics |
| 06/02/2004 | EP0891376B1 Antifungal peptides from scleroderma texense |
| 06/02/2004 | CN1501942A Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 06/02/2004 | CN1501807A Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock |
| 06/02/2004 | CN1500820A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 06/02/2004 | CN1500805A Preparing process for Eptifibatide |
| 06/02/2004 | CN1152050C Cyclopeptide compound phakellistatin 12 with anticancer activity |
| 06/01/2004 | US6743945 Carboxylic acid and amino acid or amino condensate reactants and manufacturing method therefor |
| 06/01/2004 | US6743894 Insulin-like growth factor agonist molecules |
| 06/01/2004 | US6743893 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 06/01/2004 | US6743778 Apo-AI/AII peptide derivatives |
| 06/01/2004 | US6743777 Trisphenyl acyl derivatives of the echinocandin class; candida albicans; antifungal and antiparasitic; cyclic hexapeptides having unique side chain acyl group |
| 06/01/2004 | US6743776 Cyclohexapeptides having antimicrobial activity |
| 06/01/2004 | US6743769 Active against bacteria and fungi that exhibit resistance to multiple current antibiotics; amino acid sequence selected from the group consisting of rp-1 (seq id no: 3), rp-8 (seq id no: 10), rp-11 (seq id no: 13) and rp-13 (seq id no: 14). |
| 05/27/2004 | WO2004043994A2 A retro-inverso gonadotropin-releasing hormone peptide and vaccine composition |
| 05/27/2004 | WO2004043993A2 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 05/27/2004 | WO2004043403A2 Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use |
| 05/27/2004 | WO2004043396A2 Modified carbamate-containing prodrugs and methods of synthesizing same |
| 05/27/2004 | WO2004043383A2 A new target for angiogenesis and anti-angiogenesis therapy |
| 05/27/2004 | WO2003089663A3 Methods for measuring enzyme activity |
| 05/27/2004 | WO2003064448A3 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 05/27/2004 | WO2003046567A3 Protein biopolymer markers predictive of alzheimers disease |
| 05/27/2004 | WO2002097037A8 Melanin-concentrating hormone analogs |
| 05/27/2004 | US20040102608 Multiblock copolymers having improved mechanical properties |
| 05/27/2004 | US20040102382 Targeting peptides |
| 05/27/2004 | US20040102378 Peptides as solubilizing excipients for transforming growth factor beta proteins |
| 05/27/2004 | US20040102370 Peptides that stimulate cell survival and axon regeneration |
| 05/27/2004 | US20040101864 Chemical process |
| 05/27/2004 | US20040101830 Method for identifying individual active entities from complex mixtures |
| 05/27/2004 | CA2504953A1 A new target for angiogenesis and anti-angiogenesis therapy |
| 05/26/2004 | EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/26/2004 | EP1421387A2 Cellular immunity test with peptides fixed on a solid support |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421177A2 Zinc finger binding domains for cnn |
| 05/26/2004 | EP1421116A2 Vaccine therapies and prophylactic treatments of atherosclerotic diseases |
| 05/26/2004 | EP1421109A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 05/26/2004 | EP1421108A2 Antimicrobial and anti-inflammatory peptides |
| 05/26/2004 | EP1421107A1 Peptides having antiangiogenic activity |
| 05/26/2004 | EP1421106A2 Catalysis of the cis/trans isomerisation of secondary amide peptide compounds |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420681A2 Peptide-based multimeric targeted contrast agents |
| 05/26/2004 | EP1159296B1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly) |
| 05/26/2004 | EP1056465A4 Antimicrobial peptides and derived metapeptides |
| 05/26/2004 | EP0729360B1 Linear and cyclic peptides for treatment or prevention of crohn's disease and/or ulcerative colitis |
| 05/26/2004 | CN1498898A Minor peptide of growth factor receptor KDR of specific combined blood vessel endothelium |
| 05/26/2004 | CN1151170C Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/25/2004 | US6740502 Chelation in presence of protease; bioavailability |
| 05/25/2004 | US6740325 Peptide-based vaccine for influenza |
| 05/21/2004 | WO2004042350A2 Using amines or amino acids as mobile phase modifiers in chromatography |
| 05/21/2004 | WO2004042019A2 Systems for capture and analysis of biological particles and methods using the systems |
| 05/21/2004 | WO2004041860A1 Icam-4 binding sites |
| 05/21/2004 | WO2004041297A2 Modified cytokines for use in cancer therapy |
| 05/21/2004 | WO2004041221A1 Use of 3-position cyclosporin derivatives for hair growth |
| 05/21/2004 | WO2004041151A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | CA2505476A1 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 05/21/2004 | CA2504481A1 Systems for capture and analysis of biological particles and methods using the systems |
| 05/20/2004 | US20040097453 Introducing to the subject, or to a target group of cells from the subject, an expressible polynucleotide encoding a eukaryotic heat shock protein for stimulating a therapeutic immune response |
| 05/20/2004 | US20040097413 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 05/20/2004 | US20040097403 Linkable sialyl lewis x analogs |
| 05/20/2004 | US20040096926 Compositions for the detection of enzyme activity in biological samples and methods of use thereof |
| 05/20/2004 | US20040096906 Method for screening combinatorial bead library; ligands for cancer cells |
| 05/20/2004 | US20040096898 Caloxins |
| 05/20/2004 | US20040096459 Polypeptides to be administered especially to humans and in particular for therapeutic use. The polypeptide to elicit an immune response upon administration to the human subject. |
| 05/20/2004 | US20040096442 Modified anti-egfr antibodies with reduced immunogenicity |
| 05/19/2004 | EP1419764A1 Use of an association of synergic calcium channel blocker agents for preventing or treating wrinkles and fine lines |
| 05/19/2004 | EP1419252A2 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 05/19/2004 | EP1419178A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/19/2004 | EP1419173A2 Peptides that bind to atherosclerotic lesions |
| 05/19/2004 | EP1419172A2 Bi-directional synthesis of oligoguanidine transport agents |
| 05/19/2004 | EP1151143A4 Selection of proteins using rna-protein fusions |
| 05/19/2004 | EP1107982B1 Reversible boron complexes of 1,2-(cis)-diol cyclic peptides |
| 05/19/2004 | EP0760678B9 Quantification of individual protein kinase activity |
| 05/19/2004 | EP0711173B1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 05/19/2004 | EP0682703B1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
| 05/19/2004 | CN1498225A Template-fixed peptidomimetics with antimicrobial activity |
| 05/19/2004 | CN1498224A Novel peptides as NS3-serine protease inhibitors of hepatitiscvirus |
| 05/19/2004 | CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/19/2004 | CN1150206C Bradykinin antagonist peptides incorporating N-substituted glycines |
| 05/19/2004 | CN1150028C Tri-, tetra-, penta- and polypeptides and their therapeuitc use as antidepressant agent |
| 05/18/2004 | US6737420 Compounds to treat Alzheimer's disease |
| 05/18/2004 | US6737407 Treatment of obesity |
| 05/18/2004 | US6737406 Cryptic peptides and method for their identification |
| 05/18/2004 | US6737403 Culturing microorganism streptomyces viridochromogenes, ssp. komabensis (atcc 29814) in culture medium, isolating laspartomycin, cleaving lipophilic fragment from laspartomycin, thereby yielding laspartomycin core peptide |
| 05/18/2004 | US6737398 Administering tumor necrosis factor-alpha directly to lung tissue |
| 05/18/2004 | US6737247 Detecting enzymatic activity in sample; obtain substrate, incubate with target tissue, detect amplified relaxivity of sample, evaluate enzymatic activity sample |
| 05/18/2004 | US6737077 Proteinaceous animal chew with dentally therapeutic cation |
| 05/18/2004 | US6737062 Immunogenic compositions |
| 05/18/2004 | CA2248139C Methods of alleviating neuropathic pain using prosaposin-derived peptides |